Table of Contents 3
List of Tables 5
List of Figures 5
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Trillium Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Fluorinov Pharma Raises US$1.5 Million In Venture Financing 12
Merger 13
Stem Cell Therapeutics Completes Merger With Trillium Therapeutics 13
Licensing Agreements 14
Stem Cell Therapeutics Enters Into Licensing Agreement With MaRS Innovation For Cancer Stem Cell Program 14
StemCell Technologies Enters Into Licensing Agreement With HUB Foundation for Organoid Technology 16
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 17
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University of York For Prostate Cancer Stem Cell Assets 19
StemCell Technologies Enters Into Licensing Agreement With iPS Academia Japan For Induced Pluripotent Stem Cell Technologies 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
Equity Offering 22
Trillium Therapeutics Files Shelf Prospectus to Raise up to USD150 Million 22
Trillium Therapeutics Raises USD20 Million in Private Placement of Shares 23
Trillium Therapeutics Completes Underwriters' Partial Exercise of Over-Allotment Option of Public Offering of Shares and Prefererd Shares for USD31 Million 24
Trillium Therapeutics Raises USD55.2 Million in Public Offering of Shares 26
Stem Cell Therapeutics Completes Private Placement Of Shares For US$31 Million 27
Stem Cell Therapeutics Completes Public Offering Of Units For US$3.2 Million 29
Acquisition 30
Trillium Therapeutics Acquires Fluorinov Pharma 30
Trillium Therapeutics Inc - Key Competitors 31
Trillium Therapeutics Inc - Key Employees 32
Trillium Therapeutics Inc - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Mar 09, 2018: Trillium Therapeutics Reports Annual 2017 Financial And Operating Results 34
Nov 10, 2017: Trillium Therapeutics Reports Third Quarter 2017 Financial and Operating Results 35
Aug 11, 2017: Trillium Therapeutics Reports Second Quarter 2017 Financial and Operating Results 36
May 12, 2017: Trillium Reports First Quarter 2017 Financial and Operating Results 37
Mar 10, 2017: Trillium Therapeutics Reports Annual 2016 Financial and Operating Results 38
Product News 39
04/10/2018: Trillium Therapeutics Provides Update on TTI-622 Program 39
Clinical Trials 40
Feb 02, 2017: Trillium Therapeutics Provides Update On TTI-622 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trillium Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Trillium Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Fluorinov Pharma Raises US$1.5 Million In Venture Financing 12
Stem Cell Therapeutics Completes Merger With Trillium Therapeutics 13
Stem Cell Therapeutics Enters Into Licensing Agreement With MaRS Innovation For Cancer Stem Cell Program 14
StemCell Technologies Enters Into Licensing Agreement With HUB Foundation for Organoid Technology 16
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 17
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University of York For Prostate Cancer Stem Cell Assets 19
StemCell Technologies Enters Into Licensing Agreement With iPS Academia Japan For Induced Pluripotent Stem Cell Technologies 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
Trillium Therapeutics Files Shelf Prospectus to Raise up to USD150 Million 22
Trillium Therapeutics Raises USD20 Million in Private Placement of Shares 23
Trillium Therapeutics Completes Underwriters' Partial Exercise of Over-Allotment Option of Public Offering of Shares and Prefererd Shares for USD31 Million 24
Trillium Therapeutics Raises USD55.2 Million in Public Offering of Shares 26
Stem Cell Therapeutics Completes Private Placement Of Shares For US$31 Million 27
Stem Cell Therapeutics Completes Public Offering Of Units For US$3.2 Million 29
Trillium Therapeutics Acquires Fluorinov Pharma 30
Trillium Therapeutics Inc, Key Competitors 31
Trillium Therapeutics Inc, Key Employees 32
Trillium Therapeutics Inc, Subsidiaries 33

List of Figures
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Trillium Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10